Domov › Rakovina hrubého čreva › North Carolina

Klinické štúdie Rakovina hrubého čreva v štáte North Carolina

20 štúdií pre Rakovina hrubého čreva hľadá účastníkov v zariadeniach v štáte North Carolina.

Mestá v štáte North Carolina

Oficiálny text štúdie (anglicky)

Distance-Based Exercise to Preserve Function and Prevent Disability

Novant Health Cancer Institute - Kernersville, Kernersville
Novant Health Cancer Institute - Mount Airy, Mount Airy
Novant Health Forsyth Medical Center, Winston-Salem

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07059884

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07283939

Family Communications After Genetic Testing

Southeastern Medical Oncology Center-Clinton, Clinton
CaroMont Regional Medical Center, Gastonia
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
a 2 ďalších

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07143487

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

WakeMed Raleigh Campus ( Site 0094), Raleigh

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06997497

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Durham

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Duke Cancer Center Cary, Cary
Duke Cancer Center - Investigational Chemotherapy Service, Durham
Duke Cancer Center, Durham
a 2 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Messino Cancer Center, Asheville
The University of North Carolina At Chapel Hill, Chapel Hill
Oncology Specialists of Charlotte, Charlotte

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07284849

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

UNC- Chapel Hill, Chapel Hill

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

First Health of the Carolinas, Pinehurst

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07058012

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
Southeastern Medical Oncology Center-Jacksonville, Jacksonville

Prebieha nábor

Vek 45 až 70 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Duke Cancer Center Cary, Cary
UNC Health Cancer Care Cary, Cary
Waverly Hematology Oncology, Cary
a 22 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05174169

Shield Post-Approval Study Protocol

Cary Gastroenterology Associates, Cary
University of North Carolina at Chapel Hill, Chapel Hill
University of North Carolina at Chapel Hill, Chapel Hill
a 1 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 45 až 81 · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT06880055

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Charlotte
Xencor Investigative Site, Durham

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT05433142

Integrated Cancer Repository for Cancer Research

Cape Fear Valley Health System, Fayetteville

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Durham

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Duke Cancer Center, Durham
Carolina BioOncology Institute, Huntersville

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT06040541

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

GSK Investigational Site, Durham

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 1. 2026 · NCT05855200

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Chapel Hill
Massive Bio SYNERGY-AI site, Winston-Salem

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

Virtual Research Group, Morrisville

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 8. 2025 · NCT06864338

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

University of North Carolina, Chapel Hill

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 6. 2025 · NCT03175224

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.